Nov. 21 at 5:04 PM
$CRVO I’m obsessed with how Mainz Biomed stacks up vs the big CRC players on real data - Cologuard Plus is around 95% CRC sensitivity and ~43% on advanced adenomas, Shield blood test is ~83% CRC and ~13% AA, while ColoAlert is showing ~92–97% CRC and ~82% AA with ~95–97% specificity and 100% HGD detection across DDW/ASCO datasets, that advanced adenoma spread alone is the kind of edge that gets paid in the long run 📊
